BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16935379)

  • 1. Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers.
    Jones SA; Martin GP; Brown MB
    J Control Release; 2006 Sep; 115(1):1-8. PubMed ID: 16935379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.
    Jones SA; Martin GP; Brown MB
    J Pharm Sci; 2006 May; 95(5):1060-74. PubMed ID: 16552748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical stability of peptides in polymers. 1. Effect of water on peptide deamidation in poly(vinyl alcohol) and poly(vinyl pyrrolidone) matrixes.
    Lai MC; Hageman MJ; Schowen RL; Borchardt RT; Topp EM
    J Pharm Sci; 1999 Oct; 88(10):1073-80. PubMed ID: 10514358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-drying of nanocapsules: impact of annealing on the drying process.
    Abdelwahed W; Degobert G; Fessi H
    Int J Pharm; 2006 Oct; 324(1):74-82. PubMed ID: 16904277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and properties of poly(vinyl alcohol)-stabilized liposomes.
    Mu X; Zhong Z
    Int J Pharm; 2006 Aug; 318(1-2):55-61. PubMed ID: 16624507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(vinyl alcohol) and poly(vinyl pyrrolidone) blended films for local nitric oxide release.
    Seabra AB; De Oliveira MG
    Biomaterials; 2004 Aug; 25(17):3773-82. PubMed ID: 15020153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles.
    Buttini F; Soltani A; Colombo P; Marriott C; Jones SA
    Eur J Pharm Sci; 2008 Jan; 33(1):20-8. PubMed ID: 18023332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
    Zijlstra GS; Ponsioen BJ; Hummel SA; Sanders N; Hinrichs WL; de Boer AH; Frijlink HW
    Pharm Dev Technol; 2009; 14(4):358-68. PubMed ID: 19552563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
    Abdelwahed W; Degobert G; Fessi H
    Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A; Ji Y; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban lyospheres prepared by a dimethyl sulfoxide-based spray-freeze-drying process.
    Kožák J; Chrétien C; Pellequer Y; Lamprecht A
    Int J Pharm; 2022 Nov; 627():122235. PubMed ID: 36170899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterials of PVA and PVP in medical and pharmaceutical applications: Perspectives and challenges.
    Teodorescu M; Bercea M; Morariu S
    Biotechnol Adv; 2019; 37(1):109-131. PubMed ID: 30472307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-drying of nanosuspensions, part 3: investigation of factors compromising storage stability of highly concentrated drug nanosuspensions.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2012 Jan; 101(1):354-62. PubMed ID: 21905035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release.
    Seabra AB; da Rocha LL; Eberlin MN; de Oliveira MG
    J Pharm Sci; 2005 May; 94(5):994-1003. PubMed ID: 15793801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.